APA (7th ed.) Citation

Tremblay G, Livings C, Crowe L, Kapetanakis V, & Briggs A. (2016). Determination of the most appropriate method for extrapolating overall survival data from a placebo-controlled clinical trial of lenvatinib for progressive, radioiodine-refractory differentiated thyroid cancer. Dove Medical Press.

Chicago Style (17th ed.) Citation

Tremblay G, Livings C, Crowe L, Kapetanakis V, and Briggs A. Determination of the Most Appropriate Method for Extrapolating Overall Survival Data from a Placebo-controlled Clinical Trial of Lenvatinib for Progressive, Radioiodine-refractory Differentiated Thyroid Cancer. Dove Medical Press, 2016.

MLA (9th ed.) Citation

Tremblay G, et al. Determination of the Most Appropriate Method for Extrapolating Overall Survival Data from a Placebo-controlled Clinical Trial of Lenvatinib for Progressive, Radioiodine-refractory Differentiated Thyroid Cancer. Dove Medical Press, 2016.